Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gossamer Bio, Inc. - Common Stock
(NQ:
GOSS
)
0.1981
-0.0328 (-14.21%)
Streaming Delayed Price
Updated: 3:22 PM EDT, Jun 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gossamer Bio, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Gossamer Bio to Present at Upcoming Investor Conferences
August 29, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 07, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update
August 05, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Exploring Gossamer Bio's Earnings Expectations
↗
May 14, 2025
Via
Benzinga
Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
July 14, 2025
Via
Benzinga
Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH
June 16, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
↗
June 13, 2025
Via
Stocktwits
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 06, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study
May 15, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025
May 12, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Earnings Scheduled For May 15, 2025
↗
May 15, 2025
Via
Benzinga
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 07, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference
May 07, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 08, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
March 13, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 07, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
February 03, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio to Present Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress
January 28, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 07, 2025
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 12, 2024
Via
Benzinga
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 11, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
November 07, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 07, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 02, 2024
Via
Benzinga
Gossamer Bio Announces Data Presentations at the European Respiratory Society Congress 2024
August 26, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
GOSS Stock Earnings: Gossamer Bio Misses EPS, Misses Revenue for Q2 2024
↗
August 12, 2024
GOSS stock results show that Gossamer Bio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Gossamer Bio Announces Second Quarter 2024 Financial Results and Provides Business Update
August 12, 2024
From
Gossamer Bio, Inc.
Via
Business Wire
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
↗
June 25, 2024
Oppenheimer initiated coverage on Gossamer Bio, highlighting seralutinib's clean long-term safety profile for pulmonary arterial hypertension. Seralutinib shows potential in underserved markets.
Via
Benzinga
Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying
↗
June 25, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
